Literature DB >> 27218477

Oral adaptation of the Trail Making Test: A practical review.

Tobias Kaemmerer1, Patrick Riordan2.   

Abstract

Despite being one of the most widely used measures in clinical neuropsychology, the Trail Making Test is highly reliant on intact vision and motor functioning. Given that these capacities are often compromised in patients requiring neuropsychological evaluation, various authors have proposed methods for adapting the Trail Making Test for oral administration. To date, a number of administration and score transformation methods have been proposed. We reviewed the existing literature on oral adaptation of the Trail Making Test in order to provide recommendations for practicing clinicians wishing to use the measure, and to highlight directions for future research.

Entities:  

Keywords:  Assessment/diagnosis; test construction; tests

Mesh:

Year:  2016        PMID: 27218477     DOI: 10.1080/23279095.2016.1178645

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  6 in total

1.  Altered spatiotemporal consistency of corticolimbic circuitry in euthymic pediatric bipolar disorder.

Authors:  Yongxin Guo; Jinfeng Wang; Qing Jiao; Weifang Cao; Dong Cui; Weijia Gao; Jianfeng Qiu; Linyan Su; Guangming Lu
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

2.  Adapting to the impact of the COVID-19 pandemic on a randomized controlled trial examining lifestyle behaviors on cognitive functioning in obese African American adults: Building Research in Diet and Cognition (BRIDGE).

Authors:  Marian Fitzgibbon; Lara Blumstein; Linda Schiffer; Mirjana A Antonic; Andrew McLeod; Roxanne Dakers; Leo Restrepo; Elizabeth A Boots; Jennifer C Sanchez-Flack; Lisa Tussing-Humphreys; Melissa Lamar
Journal:  Res Sq       Date:  2021-04-26

3.  Protocol for the development of versions of the Montreal Cognitive Assessment (MoCA) for people with hearing or vision impairment.

Authors:  Piers Dawes; Annie Pye; David Reeves; Wai Kent Yeung; Saima Sheikh; Chyrssoula Thodi; Anna Pavlina Charalambous; Kathleen Gallant; Ziad Nasreddine; Iracema Leroi
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

4.  Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis.

Authors:  Nuria Sola-Valls; Helena Ariño; Domingo Escudero; Elisabeth Solana; Albert Lladó; Raquel Sánchez-Valle; Yolanda Blanco; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-17

5.  A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.

Authors:  Libby A DesRuisseaux; Victoria J Williams; Alison J McManus; Anoopum S Gupta; Becky C Carlyle; Hamed Azami; Jessica A Gerber; Anna M Bolling; Carolyn L Cook; Rebecca A Betensky; Steven E Arnold
Journal:  Trials       Date:  2020-12-11       Impact factor: 2.279

6.  Adapting to the COVID-19 pandemic on Building Research in Diet and Cognition (BRIDGE) trial.

Authors:  Marian Fitzgibbon; Lara Blumstein; Linda Schiffer; Mirjana A Antonic; Andrew McLeod; Roxanne Dakers; Leo Restrepo; Elizabeth A Boots; Jennifer C Sanchez-Flack; Lisa Tussing-Humphreys; Melissa Lamar
Journal:  Trials       Date:  2021-07-16       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.